FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036703397> ?p ?o ?g. }

• W3036703397 endingPage "e04099" @default.
• W3036703397 startingPage "e04099" @default.
• W3036703397 abstract "Lannea barteri is used in the folkloric treatment of many disease states ranging from epilepsy, diarrhoea, oedema and ulcers, etc. This study investigated the antioxidant and hepatoprotective potentials of methanol (MFLB), n-hexane (nHFLB) and ethyl acetate (EFLB) leaf fractions of L. barteri and identified the active metabolites.The in vitro models used were 1, 1-diphenyl-1-picrylhydrazyl (DPPH), reducing power and thiobarbituric acid assays while in the in vivo model, carbon tetrachloride-induced oxidative liver damage in albino rats was used, and the biomarkers assayed were aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), malondialdehyde (MDA), serum total protein, serum direct and total bilirubin. Also, histopathological examination of the liver, high performance liquid chromatography (HPLC) profiling and liquid chromatography-mass spectroscopy-electrospray ionization (LC-MS-ESI) analysis of the fractions were done.In the in vitro assays, the decreasing order of DPPH free radical scavenging activity of the ascorbic acid and fractions at 400 μg/ml is as follows: ascorbic acid (86.6%), MFLB (52.8%), EFLB (36.6%), and nHFLB (28.1%). The percentage scavenging activity of the samples at 400 μg/ml in the TBA followed this pattern: ascorbic acid (117.1%), MFLB (82.2%), nHFLB (80.0%), and EFLB (46.9%). The ascorbic acid elicited highest reducing power (42.6%), followed by MFLB (22.5%), nHFLB (13.7%), and EFLB (-0.93%). The in vivo study showed significant (p < 0.0001) reduction in serum AST, ALT, and direct bilirubin with a non-significant reduction in ALP, total bilirubin and MDA, and mild elevation in total protein. Histopathological studies revealed a restorative effect on liver architecture. The phytochemical analyses revealed the presence of resins, terpenoids, flavonoids, carbohydrates, alkaloids, reducing sugar, saponins, tannins and proteins. HPLC-ESI-MS analysis revealed the presence of potentially bioactive compounds in L. barteri fractions.The fractions from L. barteri leaf possessed in vitro antioxidant and hepatoprotective potentials against CCl4-hepatic oxidative damage; therefore, proper isolation and characterization of these identified bioactive compounds responsible for the observed effects are ongoing." @default.
• W3036703397 created "2020-06-25" @default.
• W3036703397 creator A5089771931 @default.
• W3036703397 creator A5089856892 @default.
• W3036703397 date "2020-06-01" @default.
• W3036703397 modified "2023-10-11" @default.
• W3036703397 title "Antioxidant and hepatoprotective potentials of active fractions of Lannea barteri Oliv. (Anarcadiaceae) in rats" @default.
• W3036703397 cites W1878430469 @default.
• W3036703397 cites W1963343926 @default.
• W3036703397 cites W2001836100 @default.
• W3036703397 cites W2023695511 @default.
• W3036703397 cites W2029361185 @default.
• W3036703397 cites W2037880347 @default.
• W3036703397 cites W2059857647 @default.
• W3036703397 cites W2063637301 @default.
• W3036703397 cites W2066897427 @default.
• W3036703397 cites W2088263234 @default.
• W3036703397 cites W2101350128 @default.
• W3036703397 cites W2116342732 @default.
• W3036703397 cites W2134824140 @default.
• W3036703397 cites W2152448824 @default.
• W3036703397 cites W2263023695 @default.
• W3036703397 cites W2289197441 @default.
• W3036703397 cites W2299829932 @default.
• W3036703397 cites W2339265340 @default.
• W3036703397 cites W2346033263 @default.
• W3036703397 cites W2495031229 @default.
• W3036703397 cites W2520825281 @default.
• W3036703397 cites W2563671230 @default.
• W3036703397 cites W2583594489 @default.
• W3036703397 cites W2802448947 @default.
• W3036703397 cites W2888228316 @default.
• W3036703397 cites W2915441877 @default.
• W3036703397 cites W3005655931 @default.
• W3036703397 cites W746898690 @default.
• W3036703397 doi "https://doi.org/10.1016/j.heliyon.2020.e04099" @default.
• W3036703397 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7305399" @default.
• W3036703397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32577550" @default.
• W3036703397 hasPublicationYear "2020" @default.
• W3036703397 type Work @default.
• W3036703397 sameAs 3036703397 @default.
• W3036703397 citedByCount "5" @default.
• W3036703397 countsByYear W30367033972022 @default.
• W3036703397 countsByYear W30367033972023 @default.
• W3036703397 crossrefType "journal-article" @default.
• W3036703397 hasAuthorship W3036703397A5089771931 @default.
• W3036703397 hasAuthorship W3036703397A5089856892 @default.
• W3036703397 hasBestOaLocation W30367033971 @default.
• W3036703397 hasConcept C126322002 @default.
• W3036703397 hasConcept C160160445 @default.
• W3036703397 hasConcept C178790620 @default.
• W3036703397 hasConcept C181199279 @default.
• W3036703397 hasConcept C185592680 @default.
• W3036703397 hasConcept C2777359374 @default.
• W3036703397 hasConcept C2777513400 @default.
• W3036703397 hasConcept C2778004101 @default.
• W3036703397 hasConcept C2779679107 @default.
• W3036703397 hasConcept C2781401929 @default.
• W3036703397 hasConcept C2986274086 @default.
• W3036703397 hasConcept C31903555 @default.
• W3036703397 hasConcept C43617362 @default.
• W3036703397 hasConcept C55493867 @default.
• W3036703397 hasConcept C71924100 @default.
• W3036703397 hasConceptScore W3036703397C126322002 @default.
• W3036703397 hasConceptScore W3036703397C160160445 @default.
• W3036703397 hasConceptScore W3036703397C178790620 @default.
• W3036703397 hasConceptScore W3036703397C181199279 @default.
• W3036703397 hasConceptScore W3036703397C185592680 @default.
• W3036703397 hasConceptScore W3036703397C2777359374 @default.
• W3036703397 hasConceptScore W3036703397C2777513400 @default.
• W3036703397 hasConceptScore W3036703397C2778004101 @default.
• W3036703397 hasConceptScore W3036703397C2779679107 @default.
• W3036703397 hasConceptScore W3036703397C2781401929 @default.
• W3036703397 hasConceptScore W3036703397C2986274086 @default.
• W3036703397 hasConceptScore W3036703397C31903555 @default.
• W3036703397 hasConceptScore W3036703397C43617362 @default.
• W3036703397 hasConceptScore W3036703397C55493867 @default.
• W3036703397 hasConceptScore W3036703397C71924100 @default.
• W3036703397 hasIssue "6" @default.
• W3036703397 hasLocation W30367033971 @default.
• W3036703397 hasLocation W30367033972 @default.
• W3036703397 hasLocation W30367033973 @default.
• W3036703397 hasLocation W30367033974 @default.
• W3036703397 hasLocation W30367033975 @default.
• W3036703397 hasOpenAccess W3036703397 @default.
• W3036703397 hasPrimaryLocation W30367033971 @default.
• W3036703397 hasRelatedWork W1849071895 @default.
• W3036703397 hasRelatedWork W1992177238 @default.
• W3036703397 hasRelatedWork W2012758233 @default.
• W3036703397 hasRelatedWork W2113719232 @default.
• W3036703397 hasRelatedWork W2137513274 @default.
• W3036703397 hasRelatedWork W2184400626 @default.
• W3036703397 hasRelatedWork W2186272018 @default.
• W3036703397 hasRelatedWork W2414601658 @default.
• W3036703397 hasRelatedWork W4226299371 @default.
• W3036703397 hasRelatedWork W2556491762 @default.
• W3036703397 hasVolume "6" @default.
• W3036703397 isParatext "false" @default.

• next